Traditional chemotherapies can help slow down the progression of the disease, but the most impressive new drug to emerge for some time is Velcade, which is toxic to the myeloma cells, disrupting their ability to reproduce.
While not a cure, it does seem to make the cancer lie dormant, and extend life expectancy for an average of six months - longer than previously used chemotherapies were.
NICE had previously ruled in October 2006 that patients with myeloma were not eligible for the drug because it was not considered cost-effective, although its clinical effectiveness was undisputed."
Emphasis is mine. This should be all anyone needs to know about universal payer, national health care. if people are upset with the "greedy" non-profit HMOs like Blue Care Network, Health Alliance Plan, and M-Care, what are they going to think about this?
Posts
No comments:
Post a Comment